Page 7 Annual Report:-
11 Conference presentations throughout 2018-2019 all posters and presentations accepted and delivered PanCo trial data demonstrating both safety and efficacy. All delivered and presented at the world’s prestigious oncology and radiology conferences. PanCo data demonstrating resections, improved overall survival rates, disease control and tumour reduction. Data disseminated all over the world in the US, Europe and the UK. Data presented at conferences by experts and preeminent researchers in the field.
What the hell is BSI doing? BSI requested 20 supplementary data in 2016. Oncosil delivered 42 patient data with now new PanCo survival data. All presented and delivered in detailed submissions and presented in the world’s leading oncology and radiology conferences.
What happened to the CMO?, page-26
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(9.09%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $62.00K | 12.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6487586 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 24090459 | 22 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 9.09 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 6680000 | ||
| Last updated 15.48pm 28/05/2024 ? | |||||
| OSL (ASX) Chart |